149 related articles for article (PubMed ID: 36917862)
1. Generation and characterization of iPS cell line (CTGUi001-A) from skin fibroblasts of a patient with Fabry disease.
Qin Y; Zhan JQ; Ma CJ; Cao CY; Zhang Y; Min YT; Lv YF
Stem Cell Res; 2023 Jun; 69():103063. PubMed ID: 36917862
[TBL] [Abstract][Full Text] [Related]
2. Generation and characterization of iPS cell line (SYSUSHi002-A) from PBMCs of an AML patient with TP53 mutation.
Yuan L; Wang Y; Xie R; Lin D; Wang X
Stem Cell Res; 2023 Dec; 73():103230. PubMed ID: 37890328
[TBL] [Abstract][Full Text] [Related]
3. Generation of the human induced pluripotent stem cell line PUMCi005-A from a patient with Perrault syndrome.
Wang YB; Lv YF; Zhang Y; Wang W
Stem Cell Res; 2024 Mar; 75():103318. PubMed ID: 38295749
[TBL] [Abstract][Full Text] [Related]
4. Generation of a human iPSC line (HIMRi001-A) from a patient with filaminopathy.
Daya NM; Mavrommatis L; Zhuge H; Athamneh M; Roos A; Gläser D; Doering K; Zaehres H; Vorgerd M; Güttsches AK
Stem Cell Res; 2023 Oct; 72():103210. PubMed ID: 37748332
[TBL] [Abstract][Full Text] [Related]
5. Generation of induced pluripotent stem cell line NIMHi010-A from dermal fibroblast cells of a healthy individual.
Dash SS; Arunachal G; Nimonkar MM; Vengalil S; Nashi S; Chetan GK; Boddu VK; Nalini A; Markandeya YS
Stem Cell Res; 2024 Apr; 76():103355. PubMed ID: 38412659
[TBL] [Abstract][Full Text] [Related]
6. Generation of two human iPSC lines (MDCUi001-A and MDCUi001-B) from dermal fibroblasts of a Thai patient with X-linked osteogenesis imperfecta using integration-free Sendai virus.
Tongkobpetch S; Rungsiwiwut R; Pruksananonda K; Suphapeetiporn K; Shotelersuk V
Stem Cell Res; 2019 Aug; 39():101493. PubMed ID: 31326747
[TBL] [Abstract][Full Text] [Related]
7. Morphological features of iPS cells generated from Fabry disease skin fibroblasts using Sendai virus vector (SeVdp).
Kawagoe S; Higuchi T; Otaka M; Shimada Y; Kobayashi H; Ida H; Ohashi T; Okano HJ; Nakanishi M; Eto Y
Mol Genet Metab; 2013 Aug; 109(4):386-9. PubMed ID: 23810832
[TBL] [Abstract][Full Text] [Related]
8. An induced pluripotent stem cell line (CSUi004-A) from skin fibroblasts of a healthy individual.
Wang L; Zhao H; Wu J; Ren J; Luo H; Zuo X; Chen Q; Tang Y
Stem Cell Res; 2021 May; 53():102336. PubMed ID: 33865102
[TBL] [Abstract][Full Text] [Related]
9. Generation of a human iPSC line (MPIi007-A) from a patient with Metachromatic leukodystrophy.
Kim KP; Yoon J; Kim J; Röpke A; Shin B; Wook Han D; Greber B; Schöler HR
Stem Cell Res; 2020 Oct; 48():101993. PubMed ID: 32950023
[TBL] [Abstract][Full Text] [Related]
10. Generation of a human induced pluripotent stem cell line PUMCi001-A from a patient with Krabbe disease.
Wang W; Lv YF; Zhang YJ; Dong WJ; Zhang Y
Stem Cell Res; 2020 Oct; 48():101937. PubMed ID: 32763824
[TBL] [Abstract][Full Text] [Related]
11. Generation of induced pluripotent stem cell line (RCMGi012-A) from fibroblasts of patient with mucopolysaccharidosis type VI.
Kondrateva E; Grigorieva O; Panchuk I; Bychkov I; Zakharova E; Tabakov V; Pozhitnova V; Voronina E; Shchagina O; Lavrov A; Smirnikhina S; Kutsev S
Stem Cell Res; 2023 Dec; 73():103259. PubMed ID: 38006675
[TBL] [Abstract][Full Text] [Related]
12. Generation of a human iPSC line (MPIi006-A) from a patient with Pelizaeus-Merzbacher disease.
Kim KP; Yoon J; Shin B; Röpke A; Han DW; Schöler HR
Stem Cell Res; 2020 Jul; 46():101839. PubMed ID: 32446239
[TBL] [Abstract][Full Text] [Related]
13. Generation of the induced pluripotent stem cell line UKWNLi005-A derived from a patient with the GLA mutation c.376A > G of unknown pathogenicity in Fabry disease.
Breyer M; Klein T; Klug K; Klopocki E; Üçeyler N
Stem Cell Res; 2022 May; 61():102747. PubMed ID: 35325818
[TBL] [Abstract][Full Text] [Related]
14. Generation of induced pluripotent stem cell line (RCMGi009-A) from urine cells of patient with fibrodysplasia ossificans progressiva.
Kondrateva E; Grigorieva O; Kurshakova E; Panchuk I; Pozhitnova V; Voronina E; Tabakov V; Orlova M; Lavrov A; Smirnikhina S; Kutsev S
Stem Cell Res; 2023 Aug; 70():103133. PubMed ID: 37307755
[TBL] [Abstract][Full Text] [Related]
15. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
16. Generation of two human iPSC lines (HIMRi002-A and HIMRi003-A) derived from Caveolinopathy patients with rippling muscle disease.
Boeing A; Mavrommatis L; Daya NM; Zhuge H; Volke L; Kocabas A; Kneifel M; Athamneh M; Krause K; Südkamp N; Döring K; Theiss C; Roos A; Zaehres H; Güttsches AK; Vorgerd M
Stem Cell Res; 2023 Oct; 72():103220. PubMed ID: 37839261
[TBL] [Abstract][Full Text] [Related]
17. Establishment of an induced pluripotent stem cell line (CSUi003-A) from fibroblasts of a healthy elderly individual.
Zhao H; Wang L; Wu J; Ren J; Chen Q; Luo H; Zuo X; Tang Y
Stem Cell Res; 2021 May; 53():102326. PubMed ID: 33845242
[TBL] [Abstract][Full Text] [Related]
18. Generation of a human induced pluripotent stem cell line (CSC-42) from a patient with sporadic form of Parkinson's disease.
Savchenko E; Marote A; Russ K; Collin A; Goldwurm S; Roybon L; Pomeshchik Y
Stem Cell Res; 2018 Mar; 27():78-81. PubMed ID: 29334629
[TBL] [Abstract][Full Text] [Related]
19. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
Zhou W; Freed CR
Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
[TBL] [Abstract][Full Text] [Related]
20. Reprogramming of a human induced pluripotent stem cell line from one 48-year-old healthy male donor.
Guo R; Mu W; Liu X; Zhang J; Liu B; Du X; He J; Ma J; Cui H
Stem Cell Res; 2021 May; 53():102339. PubMed ID: 33892291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]